Beyond Air, Inc. — Director's Dealing 2019

Feb 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIT Therapeutics, Inc. (AITB)
CIK: 0001641631
Period of Report: 2019-02-13

Reporting Person: Carey Robert (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-13	Stock Option (right to buy)	$4.95	A	25000	Acquired	2022-12-31	Common stock (25000)	Direct

Footnotes

F1: The options will vest as to 25% of the shares on December 31, 2019 and on December 31 of each of the three ensuing years thereafter until vested in full (provided that the last vesting date shall occur on the date before the Options expire.)